Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2012

Open Access 01-12-2012 | Research article

Hyperactivity persists in male and female adults with ADHD and remains a highly discriminative feature of the disorder: a case-control study

Authors: Martin H Teicher, Ann Polcari, Nikolaos Fourligas, Gordana Vitaliano, Carryl P Navalta

Published in: BMC Psychiatry | Issue 1/2012

Login to get access

Abstract

Background

Symptoms of hyperactivity are believed to fade with age leaving ADHD adults mostly inattentive and impulsive. Our aim was to test this assertion using objective measures of hyperactivity, impulsivity and inattention.

Method

Participants were 40 subjects with ADHD (23M/17F; 35±10 yrs) and 60 healthy adults (28M/32F; 29±9 yrs) blindly assessed using Wender-Reimherr interview ratings, Structured Clinical Interview for DSM-IV Disorders and DSM-IV criteria. Infrared motion capture systems tracked head and leg movements during performance of a No-4’s cognitive control task. Subjects also completed the Conners’ CPT-II.

Results

ADHD and controls differed significantly in activity and attention. Effect sizes for activity measures (d’ = 0.7–1.6) were, on average, two-fold larger than differences in attention or impulsivity, correlated more strongly with executive function ratings and were more discriminatory (ROC area = 0.83 for activity composite, 0.65 for No-4’s distraction composite, 0.63 for Conners’ CPT-II confidence index, 0.96 for the combined activity and attention diagnostic index). This finding was true for subjects with the predominantly inattentive subtype as well as subjects with combined or predominantly hyperactive/impulsive subtype. Males and females with ADHD were equally active. The superior accuracy of activity measures was confirmed using Random Forest and predictive modeling techniques.

Conclusions

Objectively measured hyperactivity persists in adults with ADHD and is a more discriminative feature of the disorder than computerized measures of inattention or impulsivity. This finding supports the hypothesis that a deficient ability to sit still remains a defining feature of the disorder in adults when it is measured objectively.
Appendix
Available only for authorised users
Literature
1.
APA APA: Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition (DSM-IV). 1994, Washington, DC: American Psychiatric Association
2.
Wender PH: Attention-Deficit Hyperactivity Disorder in Adults. 1995, New York: Oxfrod University Press
3.
Teicher MH: Actigraphy and motion analysis: new tools for psychiatry. Harv Rev Psychiatry. 1995, 3 (1): 18-35. 10.3109/10673229509017161.CrossRefPubMed
4.
Porrino LJ, Rapoport JL, Behar D, Sceery W, Ismond DR, Bunney WE: A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiatry. 1983, 40 (6): 681-687. 10.1001/archpsyc.1983.04390010091012.CrossRefPubMed
5.
Teicher MH, Ito Y, Glod CA, Barber NI: Objective measurement of hyperactivity and attentional problems in ADHD. J Am Acad Child Adolesc Psychiatry. 1996, 35 (3): 334-342. 10.1097/00004583-199603000-00015.CrossRefPubMed
6.
Teicher MH, Anderson CM, Polcari A, Glod CA, Maas LC, Renshaw PF: Functional deficits in basal ganglia of children with attention- deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry. Nat Med. 2000, 6 (4): 470-473. 10.1038/74737.CrossRefPubMed
7.
Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L: Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry. 2005, 57 (3): 229-238. 10.1016/j.biopsych.2004.11.009.CrossRefPubMed
8.
First MB, Spitzer RL, Gibbon M, Williams JBW: Structured clinical interview for DSM-IV axis I disorders - clinician version (SCID-CV). 1997, Washington, DCWashington, DC : American Psychiatric Press
9.
Ward MF, Wender PH, Reimherr FW: The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 1993, 150 (6): 885-890.CrossRefPubMed
10.
Brown TE: Brown attention deficit disorder scales for adolescents and adults. 1996, San Antonio, TX: The Psychological Corporation
11.
Kellner R: A symptom questionnaire. J Clin Psychiatry. 1987, 48 (7): 268-273.PubMed
12.
Banaschewski T, Yordanova J, Kolev V, Heinrich H, Albrecht B, Rothenberger A: Stimulus context and motor preparation in attention-deficit/hyperactivity disorder. Biol Psychol. 2008, 77 (1): 53-62. 10.1016/j.biopsycho.2007.09.003.CrossRefPubMed
13.
Teicher MH, Lowen SB, Polcari A, Foley M, McGreenery CE: Novel strategy for the analysis of CPT data provides new insight into the effects of methylphenidate on attentional states in children with ADHD. J Child Adolesc Psychopharmacol. 2004, 14 (2): 219-232. 10.1089/1044546041648995.CrossRefPubMed
14.
Paulus MP, Geyer MA: The effectiveness of MDMA and other methylenedioxy-substituted pheylalklamines on the structure of rat locomotor activity. Neuropsychopharmacology. 1992, 7: 15-31.PubMed
15.
16.
Hochberg Y, Benjamini Y: More powerful procedures for multiple significance testing. Stat Med. 1990, 9 (7): 811-818. 10.1002/sim.4780090710.CrossRefPubMed
17.
Cohen J: Statistical Power Analysis for the Behavioral Sciences. 1988, New York: Academic Press, 2
18.
Langlotz CP: Fundamental measures of diagnostic examination performance: usefulness for clinical decision making and research. Radiology. 2003, 228 (1): 3-9. 10.1148/radiol.2281011106.CrossRefPubMed
19.
DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988, 44 (3): 837-845. 10.2307/2531595.CrossRefPubMed
20.
Breiman L: Random Forests. Machine Learning. 2001, 45: 5-32. 10.1023/A:1010933404324.CrossRef
21.
Liaw A, Wiener M: Classification and Regression by randomForest. R News. 2002, 2/3: 18-22.
22.
Strobl C, Boulesteix AL, Zeileis A, Hothorn T: Bias in random forest variable importance measures: illustrations, sources and a solution. BMC Bioinformatics. 2007, 8: 25-10.1186/1471-2105-8-25.CrossRefPubMedPubMedCentral
23.
Kuhn M: Building predictive models in R using the caret package. J Stat Softw. 2008, 28 (5): 1-26.CrossRef
24.
Barkley RA, Murphy KR: Impairment in occupational functioning and adult ADHD: the predictive utility of executive function (EF) ratings versus EF tests. Arch Clin Neuropsychol. 2010, 25 (3): 157-173. 10.1093/arclin/acq014.CrossRefPubMedPubMedCentral
25.
Barkley RA: Differential diagnosis of adults with ADHD: the role of executive function and self-regulation. J Clin Psychiatry. 2010, 71 (7): e17-10.4088/JCP.9066tx1c.CrossRefPubMed
26.
Brown TE: ADD/ADHD and Impaired Executive Function in Clinical Practice. Curr Psychiatry Rep. 2008, 10 (5): 407-411. 10.1007/s11920-008-0065-7.CrossRefPubMed
27.
28.
Ohashi K, Vitaliano G, Polcari A, Teicher MH: Unraveling the nature of hyperactivity in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2010, 67 (4): 388-396. 10.1001/archgenpsychiatry.2010.28.CrossRefPubMed
29.
Abikoff H, Courtney M, Pelham WE, Koplewicz HS: Teachers' ratings of disruptive behaviors: the influence of halo effects. J Abnorm Child Psychol. 1993, 21 (5): 519-533. 10.1007/BF00916317.CrossRefPubMed
30.
Alderson RM, Rapport MD, Kofler MJ: Attention-deficit/hyperactivity disorder and behavioral inhibition: a meta-analytic review of the stop-signal paradigm. J Abnorm Child Psychol. 2007, 35 (5): 745-758. 10.1007/s10802-007-9131-6.CrossRefPubMed
31.
van Mourik R, Oosterlaan J, Sergeant JA: The Stroop revisited: a meta-analysis of interference control in AD/HD. J Child Psychol Psychiatry. 2005, 46 (2): 150-165. 10.1111/j.1469-7610.2004.00345.x.CrossRefPubMed
32.
Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF: Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry. 2005, 57 (11): 1336-1346. 10.1016/j.biopsych.2005.02.006.CrossRefPubMed
33.
Balint S, Czobor P, Komlosi S, Meszaros A, Simon V, Bitter I: Attention deficit hyperactivity disorder (ADHD): gender- and age-related differences in neurocognition. Psychol Med. 2009, 39 (8): 1337-1345. 10.1017/S0033291708004236.CrossRefPubMed
34.
Schweiger A, Abramovitch A, Doniger GM, Simon ES: A clinical construct validity study of a novel computerized battery for the diagnosis of ADHD in young adults. J Clin Exp Neuropsychol. 2007, 29 (1): 100-111. 10.1080/13803390500519738.CrossRefPubMed
35.
Andreou P, Neale BM, Chen W, Christiansen H, Gabriels I, Heise A, Meidad S, Muller UC, Uebel H, Banaschewski T, et al: Reaction time performance in ADHD: improvement under fast-incentive condition and familial effects. Psychol Med. 2007, 37 (12): 1703-1715.CrossRefPubMedPubMedCentral
36.
Slusarek M, Velling S, Bunk D, Eggers C: Motivational effects on inhibitory control in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2001, 40 (3): 355-363. 10.1097/00004583-200103000-00016.CrossRefPubMed
37.
Kohls G, Herpertz-Dahlmann B, Konrad K: Hyperresponsiveness to social rewards in children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Behav Brain Funct. 2009, 5: 20-10.1186/1744-9081-5-20.CrossRefPubMedPubMedCentral
38.
Liddle EB, Hollis C, Batty MJ, Groom MJ, Totman JJ, Liotti M, Scerif G, Liddle PF: Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate. J Child Psychol Psychiatry. 2011, 52 (7): 761-771. 10.1111/j.1469-7610.2010.02333.x.CrossRefPubMed
39.
Kuntsi J, Wood AC, Van Der Meere J, Asherson P: Why cognitive performance in ADHD may not reveal true potential: findings from a large population-based sample. J Int Neuropsychol Soc. 2009, 15 (4): 570-579. 10.1017/S135561770909081X.CrossRefPubMedPubMedCentral
40.
Barkley RA: Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997, 121 (1): 65-94.CrossRefPubMed
41.
Aron AR, Poldrack RA: The cognitive neuroscience of response inhibition: relevance for genetic research in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005, 57 (11): 1285-1292. 10.1016/j.biopsych.2004.10.026.CrossRefPubMed
42.
Casey BJ, Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Schubert AB, Vauss YC, Vaituzis AC, Dickstein DP, Sarfatti SE, et al: Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1997, 36 (3): 374-383. 10.1097/00004583-199703000-00016.CrossRefPubMed
43.
Arnsten AF: Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J Clin Psychiatry. 2006, 67 (Suppl 8): 7-12.PubMed
44.
de Zubicaray GI, Andrew C, Zelaya FO, Williams SC, Dumanoir C: Motor response suppression and the prepotent tendency to respond: a parametric fMRI study. Neuropsychologia. 2000, 38 (9): 1280-1291. 10.1016/S0028-3932(00)00033-6.CrossRefPubMed
45.
Dickstein SG, Bannon K, Castellanos FX, Milham MP: The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J Child Psychol Psychiatry. 2006, 47 (10): 1051-1062. 10.1111/j.1469-7610.2006.01671.x.CrossRefPubMed
46.
Dillon DG, Pizzagalli DA: Inhibition of Action, Thought, and Emotion: A Selective Neurobiological Review. Appl Prev Psychol. 2007, 12 (3): 99-114. 10.1016/j.appsy.2007.09.004.CrossRefPubMedPubMedCentral
47.
Feenstra MG, Botterblom MH, van Uum JF: Behavioral arousal and increased dopamine efflux after blockade of NMDA-receptors in the prefrontal cortex are dependent on activation of glutamatergic neurotransmission. Neuropharmacology. 2002, 42 (6): 752-763. 10.1016/S0028-3908(02)00029-1.CrossRefPubMed
48.
Paine TA, Neve RL, Carlezon WA: Attention deficits and hyperactivity following inhibition of cAMP-dependent protein kinase within the medial prefrontal cortex of rats. Neuropsychopharmacology. 2009, 34 (9): 2143-2155. 10.1038/npp.2009.40.CrossRefPubMedPubMedCentral
49.
Teicher MH, Anderson CM, Polcari A, Renshaw PF: T2-Relaxometry measures of prefrontal cortex, putamen and vermal balance fully account for differences in activity between children with ADHD and healthy controls. Biol Psychiatry. 2006, 59 (8S): 111S-112S.
50.
Pangelinan MM, Zhang G, VanMeter JW, Clark JE, Hatfield BD, Haufler AJ: Beyond age and gender: relationships between cortical and subcortical brain volume and cognitive-motor abilities in school-age children. Neuroimage. 2011, 54 (4): 3093-3100. 10.1016/j.neuroimage.2010.11.021.CrossRefPubMed
51.
Wunderlich K, Dayan P, Dolan RJ: Mapping value based planning and extensively trained choice in the human brain. Nat Neurosci. 2012, 15 (5): 786-791. 10.1038/nn.3068.CrossRefPubMedPubMedCentral
52.
53.
Simard F, Joanette Y, Petrides M, Jubault T, Madjar C, Monchi O: Fronto-striatal contribution to lexical set-shifting. Cereb Cortex. 2011, 21 (5): 1084-1093. 10.1093/cercor/bhq182.CrossRefPubMed
54.
Ystad M, Hodneland E, Adolfsdottir S, Haasz J, Lundervold AJ, Eichele T, Lundervold A: Cortico-striatal connectivity and cognition in normal aging: a combined DTI and resting state fMRI study. Neuroimage. 2011, 55 (1): 24-31. 10.1016/j.neuroimage.2010.11.016.CrossRefPubMed
55.
Hartberg CB, Sundet K, Rimol LM, Haukvik UK, Lange EH, Nesvag R, Melle I, Andreassen OA, Agartz I: Subcortical brain volumes relate to neurocognition in schizophrenia and bipolar disorder and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35 (4): 1122-1130. 10.1016/j.pnpbp.2011.03.014.CrossRefPubMed
56.
Brooks DJ: Dopaminergic action beyond its effects on motor function: imaging studies. J Neurol. 2006, 253 (Suppl 4): IV8-IV15.PubMed
57.
Epstein JN, Conners CK, Sitarenios G, Erhardt D: Continuous performance test results of adults with attention deficit hyperactivity disorder. Clin Neuropsychol. 1998, 12 (2): 155-168. 10.1076/clin.12.2.155.2000.CrossRef
58.
Edwards MC, Gardner ES, Chelonis JJ, Schulz EG, Flake RA, Diaz PF: Estimates of the validity and utility of the Conners' Continuous Performance Test in the assessment of inattentive and/or hyperactive-impulsive behaviors in children. J Abnorm Child Psychol. 2007, 35 (3): 393-404. 10.1007/s10802-007-9098-3.CrossRefPubMed
Metadata
Title
Hyperactivity persists in male and female adults with ADHD and remains a highly discriminative feature of the disorder: a case-control study
Authors
Martin H Teicher
Ann Polcari
Nikolaos Fourligas
Gordana Vitaliano
Carryl P Navalta
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2012
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-12-190

Other articles of this Issue 1/2012

BMC Psychiatry 1/2012 Go to the issue

Research article

Effectiveness of a psycho-educational group program for major depression in primary care: a randomized controlled trial

Research article

Quality of care for major depression and its determinants: a multilevel analysis

Research article

Effective lifestyle interventions to improve type II diabetes self-management for those with schizophrenia or schizoaffective disorder: a systematic review

Research article

Reference values for generic instruments used in routine outcome monitoring: the leiden routine outcome monitoring study

Research article

The prevalence and characteristics of suicidality in HIV/AIDS as seen in an African population in Entebbe district, Uganda

Research article

A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia